News

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...
The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...
Definitive radiotherapy is the standard treatment for head and neck squamous cell carcinoma ... support through a grant from the Dutch Cancer Society. The authors reported having no relevant ...
HPV-related throat cancers are rising, but risks can be lowered by avoiding tobacco, limiting alcohol, getting vaccinated, ...
Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of. April serves as Head and Neck Cancer Awareness ...
That question is even more relevant because Roche’s PD-L1 inhibitor Tecentriq failed in its own study when used as an adjuvant therapy after head and neck cancer surgery. Uppaluri admitted that ...
Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival ...
Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival ...